Aap Implantate AG Achieves Unanimous Approval for Bond Terms Amendment

aap Implantate AG ("aap" or the "Company") announced on April 3, 2024, a landmark approval regarding the amendment of the terms and conditions of their mandatory convertible bond spanning 2023 to 2028. The decision came through a bondholders' vote without a meeting, where 100% of the votes cast were in favor of the proposed changes.

The vote saw participation from 86.03% of the total nominal amount and votes of all outstanding bonds, demonstrating a high level of engagement from the bondholders. The company has expressed its gratitude towards the creditors for their unanimous support, which underlines a strong confidence in the company’s future prospects.

The primary alteration in the bond terms grants bondholders the right to opt for conversion without adhering to a previously mandatory lock-up period. Moreover, this amendment allows for an earlier conversion right, now permissible as of May 2024, offering greater flexibility to the bondholders.

This unanimous decision is a significant milestone for aap Implantate AG, fostering trust and solidarity between the company and its creditors, which could positively influence future financial maneuvers and company strategies.